Monograph Details
|
|
Dermatological Disorders
> Acne
|
|
CLARIFOAM EF |
| Manufacturer |
|
Onset Therapeutics |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Antibacterial + keratolytic. |
| Generic Name |
|
Sodium sulfacetamide 10%, sulfur 5%; emollient foam; contains alcohol, parabens. |
| Indications |
|
Acne vulgaris. Seborrheic dermatitis. |
| Children |
|
Not applicable. |
| Adults |
|
Apply thin film 1–3 times daily. |
| Contraindications |
|
Renal dysfunction. |
| Precautions |
|
Discontinue if sensitization occurs. Denuded or abraded skin. Avoid eyes, lips, mucous membranes. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Local irritation; rare: hypersensitivity reactions (eg, Stevens-Johnson syndrome), systemic toxic reactions. |
| How Supplied |
|
Foam—60g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
